利伐沙班

利伐沙班
臨床資料
商品名英语Drug nomenclatureXarelto, others
其他名稱BAY 59-7939
AHFS/Drugs.comMonograph
MedlinePlusa611049
核准狀況
懷孕分級
给药途径By mouth
ATC碼
法律規範狀態
法律規範
藥物動力學數據
生物利用度80–100%; Cmax = 2–4 hours (10 mg oral)[4]
药物代谢CYP3A4, CYP2J2 and CYP-independent mechanisms[4]
生物半衰期5–9 hours in healthy subjects aged 20 to 45[4][5]
排泄途徑2/3 metabolized in liver and 1/3 eliminated unchanged[4]
识别信息
  • (S)-5-chloro-N-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)
    phenyl]oxazolidin-5-yl]methyl} thiophene-2-carboxamide
CAS号366789-02-8  checkY
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB配體ID
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.210.589 編輯維基數據鏈接
化学信息
化学式C19H18ClN3O5S
摩尔质量435.88 g·mol−1
3D模型(JSmol英语JSmol
  • O=C1COCCN1c2ccc(cc2)N3C[C@@H](OC3=O)CNC(=O)c4ccc(s4)Cl
  • InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1 checkY
  • Key:KGFYHTZWPPHNLQ-AWEZNQCLSA-N checkY

利伐沙班(英语:Rivaroxaban),以Xarelto等品牌销售,是一种用于治疗和预防血栓抗凝药物(血液稀释剂)。具体而言,它用于治疗深静脉血栓形成和肺栓塞,并预防心房颤动和髋关节或膝关节手术后的血栓。它是口服的。[6]

常见的副作用包括出血。[6]其他严重的副作用可能包括脊髓硬膜外血肿过敏性休克[6]目前尚不清楚在怀孕哺乳期间使用是否安全。[1]华法林相比,它与其他药物的相互作用较少。[7]它通过阻断凝血蛋白凝血因子Xa的活性起作用。[6]

利伐沙班于2007年获得专利,并于2011年在美国获批用于医疗用途。[8]在美国,直到 2024 年它才能作为仿制药使用。[9][10]它被列入世界卫生组织基本药物标准清单里。[11]在2019年,它是美国第91种最常用的处方药,有超过800万张处方。[12][13]

历史

利伐沙班最初由拜耳公司开发的。[14]在美国,它由杨森制药强生公司的一部分)销售。[14]它是第一个口服的直接凝血因子Xa抑制剂[15]

医用

产品包装的显示。

在非瓣膜性心房颤动患者中,它在预防缺血性中风和栓塞事件方面似乎与华法林一样有效。[16][17]与华法林相比,利伐沙班与严重和致命出血事件的发生率较低相关,尽管利伐沙班与消化道出血率较高有关。[18]

2012年7月,英国国家健康与临床卓越研究所推荐利伐沙班预防和治疗静脉血栓[19]

由于与控制出血相关的困难,利伐沙班应在手术前至少24小时停用,然后在确定充分止血后立即重新开始。[20]

剂量建议不建议将利伐沙班与已知为强联合CYP3A4/P-糖蛋白抑制剂的药物合用,因为这会导致利伐沙班的血浆浓度显着升高。[2][21]

不利影响

最严重的不良反应是出血,包括严重的内出血[22][23][24]与华法林相比,利伐沙班的严重和致命出血事件发生率较低,但消化道出血发生率较高。[25]

截止2015年,上市后评估显示肝毒性,需要进一步研究来量化这种风险。[26][27]在2015年,在FDA不良事件报告系统(AERS)的定期监测药物中,利伐沙班被报告的严重伤害病例数最多。[28]

逆转剂

2014年10月,Portola Pharmaceuticals完成了andexanet alfa作为凝血因子Xa抑制剂的解毒剂且副作用少的I期和II期临床试验,并启动了三期试验。[29][30] Andexanet alfa于2018年5月获得美国食品和药物管理局的批准,商品名为 Andexxa。[31][32]

作用机制

利伐沙班抑制凝血酶原酶复合物中游离和结合的凝血因子Xa[33]它是一种选择性直接凝血因子Xa抑制剂,起效时间为2.5至4小时。[34]凝血因子Xa的抑制会中断凝血级联的内在和外在途径,从而抑制凝血酶的形成和血栓的发展。利伐沙班不抑制凝血酶(激活的凝血因子II),并且已证明对血小板没有影响。[4]它允许可预测的抗凝和剂量调整以及常规凝血监测;[4]不需要饮食限制。[35]

普通肝素低分子量肝素磺达肝素也通过与循环抗凝血酶结合而间接抑制凝血因子Xa的活性并且必须通过注射,而口服活性华法林、苯丙香豆素醋硝香豆素维生素K拮抗剂,可降低许多凝血因子,包括凝血因子Xa。[36]

利伐沙班在广泛的患者(年龄、性别、体重、种族)中具有可预测的药物代谢动力学,并且在八倍剂量范围(5-40mg)内具有平坦的剂量反应[37]口服生物利用度是剂量依赖性的。[38]10mg以下的利伐沙班剂量可以在有或没有食物的情况下服用,因为它显示出高生物利用度,而与是否食用食物无关。[39]如果以15mg或20mg口服剂量给予利伐沙班,则需要与食物一起服用以帮助药物吸收并达到适当的生物利用度(≥80%)。[39]

化学

Chemical structures of linezolid (top) and rivaroxaban (bottom). The shared structure is shown in blue.

利伐沙班与抗生素利奈唑胺有着惊人的结构相似性:两种药物具有相同的𫫇唑烷酮衍生核心结构。[40]因此,利伐沙班已被研究了任何可能的抗菌作用和线粒体毒性的可能性,线粒体毒性是长期使用利奈唑胺的已知并发症。[41]研究发现,利伐沙班及其代谢物都对革兰氏阳性菌没有任何抗生素作用。[來源請求]至于线粒体毒性,2008年之前发表的体外研究发现风险很低。[40]

社会与文化

经济性

根据美国最大的药房福利管理公司快捷药方的数据,使用利伐沙班而非华法林的成本要高出70倍。[4]截至2016年,拜耳公司声称该药物已在130个国家获得许可,超过2300万患者接受了治疗。[42]

同意许可

在2008年9月,加拿大卫生部授予利伐沙班的上市许可,用于预防接受选择性全髋关节置换术或全膝关节置换术患者的静脉血栓。[43]

同月,欧盟委员会也授予利伐沙班的上市许可,用于预防接受择期髋关节和膝关节置换术的成人静脉血栓栓塞症。[44][3]

在2011年7月1日,美国食品和药物管理局批准利伐沙班在接受髋关节和膝关节置换手术的成人中预防可能导致肺栓塞深静脉血栓形成。

在2011年11月4日,美国FDA批准利伐沙班用于非瓣膜心房颤动患者的卒中预防。[45]

合法举动

在2019年3月25日,在美国有25,000多起关于利伐沙班的诉讼以7.75亿美元和解,以支付给受影响的人。原告指责制药商没有警告出血风险,声称如果向医生和患者提供足够的信息,他们的伤害是可以避免的。[46]

研究

杜克大学医学院的研究人员被指控隐瞒用于评估利伐沙班的临床数据。[47]杜克大学在一项名为ROCKET AF试验的临床试验中测试了利伐沙班。[48]该临床试验于2011年发表在《新英格兰医学杂志》上[49]并由时任FDA专员罗伯特·卡利夫领导,[50][49]发现利伐沙班在降低房颤患者缺血性卒中的可能性方面比华法林更有效。[49]该研究的有效性在2014年受到质疑,当时制药赞助商拜耳公司和强生公司透露所使用的INRatio血液监测设备运行不正常。[47][48]杜克团队随后在2016年2月发表的一项分析发现,这对于试验的疗效和安全性没有显着影响。[51]

临床试验中少数族裔的代表性不足已经被经注意到。与华法林相比,不同种族亚组的疗效和安全性相似。[49]

参考文献

  1. ^ 1.0 1.1 Rivaroxaban Use During Pregnancy. Drugs.com. [March 3, 2019]. (原始内容存档于2019-03-27). 
  2. ^ 2.0 2.1 Xarelto- rivaroxaban tablet, film coated Xarelto- rivaroxaban tablet, film coated Xarelto- rivaroxaban kit. DailyMed. [November 13, 2020]. (原始内容存档于2021-04-19). 
  3. ^ 3.0 3.1 Xarelto EPAR. European Medicines Agency (EMA). [November 13, 2020]. (原始内容存档于2023-01-27). 
  4. ^ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Xarelto: Summary of Product Characteristics. Bayer Schering Pharma AG. 2008 [February 11, 2009]. (原始内容存档于2010-07-27). 
  5. ^ Abdulsattar Y, Bhambri R, Nogid A. Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor. P & T. May 2009, 34 (5): 238–44. PMC 2697099可免费查阅. PMID 19561868. 
  6. ^ 6.0 6.1 6.2 6.3 Rivaroxaban Monograph for Professionals. Drugs.com. American Society of Health-System Pharmacists. [March 3, 2019]. (原始内容存档于2019-03-27). 
  7. ^ Kiser K. Oral Anticoagulation Therapy: Cases and Clinical Correlation. Springer. 2017: 11. ISBN 9783319546438. 
  8. ^ Generic Xarelto Availability. Drugs.com. [May 9, 2017]. (原始内容存档于2018-06-16). 
  9. ^ Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. www.accessdata.fda.gov. [April 24, 2019]. (原始内容存档于2020-09-13). 
  10. ^ Bayer, J&J Win Ruling That Upholds Patent for Xarelto Drug. April 22, 2019 [April 24, 2019]. (原始内容存档于2019-08-01). 
  11. ^ World Health Organization. World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. hdl:10665/345533可免费查阅. WHO/MHP/HPS/EML/2021.02. 
  12. ^ The Top 300 of 2019. ClinCalc. [October 16, 2021]. (原始内容存档于2020-03-18). 
  13. ^ Rivaroxaban - Drug Usage Statistics. ClinCalc. [October 16, 2021]. (原始内容存档于2020-07-08). 
  14. ^ 14.0 14.1 Xarelto FDA Approval History. 7 September 2020 [2022-09-20]. (原始内容存档于2022-09-22). 
  15. ^ Fassiadis N. Rivaroxaban, the first oral, direct factor Xa inhibitor. Expert Opinion on Pharmacotherapy. December 2009, 10 (18): 2945–2946. PMID 19925048. S2CID 23498967. doi:10.1517/14656560903413559. 
  16. ^ Lowenstern A, Al-Khatib SM, Sharan L, Chatterjee R, Allen LaPointe NM, Shah B, et al. Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review. Annals of Internal Medicine. December 2018, 169 (11): 774–787. PMC 6825839可免费查阅. PMID 30383133. doi:10.7326/M18-1523. 
  17. ^ Gómez-Outes A, Terleira-Fernández AI, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups. Thrombosis. 2013, 2013: 640723. PMC 3885278可免费查阅. PMID 24455237. doi:10.1155/2013/640723可免费查阅. 
  18. ^ Brown DG, Wilkerson EC, Love WE. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. Journal of the American Academy of Dermatology. March 2015, 72 (3): 524–34. PMID 25486915. doi:10.1016/j.jaad.2014.10.027. 
  19. ^ Overview | Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism | Guidance | NICE. www.nice.org.uk. [January 1, 2020]. (原始内容存档于2020-05-13). 
  20. ^ Sunkara T, Ofori E, Zarubin V, Caughey ME, Gaduputi V, Reddy M. Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review. Health Services Insights. 2016, 9 (Suppl 1): 25–36. PMC 5156547可免费查阅. PMID 28008269. doi:10.4137/HSI.S40701. 
  21. ^ Mueck W, Kubitza D, Becka M. Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects. British Journal of Clinical Pharmacology. September 2013, 76 (3): 455–66. PMC 3769672可免费查阅. PMID 23305158. doi:10.1111/bcp.12075. 
  22. ^ Medication Guide – Xarelto (PDF). U.S. Food and Drug Administration. [September 1, 2014]. (原始内容存档 (PDF)于2014-05-02). 
  23. ^ Xarelto Side Effects. WebMD. [September 1, 2014]. (原始内容存档于2014-09-03). 
  24. ^ Xarelto Side Effects Center. RxList. [September 1, 2014]. (原始内容存档于2014-09-03). 
  25. ^ 引用错误:没有为名为Brown20152的参考文献提供内容
  26. ^ Raschi E, Poluzzi E, Koci A, Salvo F, Pariente A, Biselli M, et al. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system. British Journal of Clinical Pharmacology. August 2015, 80 (2): 285–93. PMC 4541976可免费查阅. PMID 25689417. doi:10.1111/bcp.12611. 
  27. ^ Russmann S, Niedrig DF, Budmiger M, Schmidt C, Stieger B, Hürlimann S, Kullak-Ublick GA. Rivaroxaban postmarketing risk of liver injury (PDF). Journal of Hepatology. August 2014, 61 (2): 293–300 [2022-09-20]. PMID 24681117. doi:10.1016/j.jhep.2014.03.026. (原始内容存档 (PDF)于2018-12-11). 
  28. ^ Schroeder C. ISMP Ranks Xarelto Most Dangerous Drug in the United States. DrugNews. DrugNews. [August 10, 2016]. (原始内容存档于2016-08-11). 
  29. ^ Schroeder C. Possible Antidote Could Help Blood Thinner Patients In Bleeding Emergencies. DrugNews. [August 20, 2015]. (原始内容存档于2015-05-10). 
  30. ^ Mo Y, Yam FK. Recent advances in the development of specific antidotes for target-specific oral anticoagulants. Pharmacotherapy. February 2015, 35 (2): 198–207. PMID 25644580. S2CID 22593448. doi:10.1002/phar.1532. 
  31. ^ Accelerated Approval for AndexXa (PDF). FDA. [August 1, 2018]. (原始内容存档 (PDF)于2018-07-26). 
  32. ^ U.S. FDA Approves Portola Pharmaceuticals' Andexxa®, First and Only Antidote for the Reversal of Factor Xa Inhibitors. Portola Pharmaceuticals Inc. (GlobeNewswire News Room). [August 1, 2018]. (原始内容存档于2021-04-10). 
  33. ^ Roehrig S, Straub A, Pohlmann J, Lampe T, Pernerstorfer J, Schlemmer KH, et al. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor. Journal of Medicinal Chemistry. September 2005, 48 (19): 5900–8. PMID 16161994. doi:10.1021/jm050101d. 
  34. ^ Ansell J. Outpatient Oral Anticoagulant Therapy. Consultative Hemostasis and Thrombosis Fourth. Elsevier. January 2019: 747–777. ISBN 978-0-323-46202-0. doi:10.1016/B978-0-323-46202-0.00037-6. 
  35. ^ Berkrot B. New blood thinner 'antidote' to help doctors move past warfarin. Reuters. December 23, 2015 [2022-09-20]. (原始内容存档于2019-04-03). 
  36. ^ Turpie AG. New oral anticoagulants in atrial fibrillation. European Heart Journal. January 2008, 29 (2): 155–65. PMID 18096568. doi:10.1093/eurheartj/ehm575可免费查阅. 
  37. ^ Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, et al. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation. November 2006, 114 (22): 2374–2381. PMID 17116766. doi:10.1161/CIRCULATIONAHA.106.642074可免费查阅. 
  38. ^ 引用错误:没有为名为Xarelto FDA label2的参考文献提供内容
  39. ^ 39.0 39.1 Stampfuss J, Kubitza D, Becka M, Mueck W. The effect of food on the absorption and pharmacokinetics of rivaroxaban. International Journal of Clinical Pharmacology and Therapeutics. July 2013, 51 (7): 549–561. PMID 23458226. doi:10.5414/CP201812. 
  40. ^ 40.0 40.1 European Medicines Agency. CHP Assessment Report for Xarelto (EMEA/543519/2008) (PDF). 2008 [June 11, 2009]. [永久失效連結]
  41. ^ Singh AK, Noronha V, Gupta A, Singh D, Singh P, Singh A, Singh A. Rivaroxaban: Drug review. Cancer Res Stat Treat. 2020, 3: 264–269. doi:10.4103/CRST.CRST_122_19. 
  42. ^ Bayer comments on article in The British Medical Journal (BMJ) regarding Xarelto (PDF). Bayer AG Communications, Government Relations & Corporate Brand. September 29, 2016 [2022-09-20]. (原始内容存档 (PDF)于2017-01-31). 
  43. ^ Bayer's Xarelto Approved in Canada (新闻稿). Bayer. September 16, 2008 [January 31, 2010]. (原始内容存档于2011-07-11). 
  44. ^ Bayer's Novel Anticoagulant Xarelto now also approved in the EU (新闻稿). Bayer. February 10, 2008 [January 31, 2010]. (原始内容存档于2008-10-22). 
  45. ^ FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm. US Food and Drug Association. November 4, 2011 [April 27, 2016]. (原始内容存档于2011-11-05). 
  46. ^ Bayer, Johnson & Johnson settle more than 25,000 lawsuits over blood thinner Xarelto for $775 million. washingtonpost.com. [April 7, 2019]. (原始内容存档于2019-03-26). 
  47. ^ 47.0 47.1 Thomas K. Document Claims Drug Makers Deceived a Top Medical Journal. The New York Times. March 1, 2016 [May 3, 2016]. (原始内容存档于2016-03-05). 
  48. ^ 48.0 48.1 Patel V. Duke clinical trial under scrutiny in drug case. The Chronicle. Duke Student Publishing Company. [2022-09-20]. (原始内容存档于2016-05-08). 
  49. ^ 49.0 49.1 49.2 49.3 Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. The New England Journal of Medicine. September 2011, 365 (10): 883–91. PMC 3860773可免费查阅. PMID 21830957. doi:10.1056/NEJMoa1009638. 
  50. ^ Meet Robert M. Califf, M.D., Commissioner of Food and Drugs. U.S. Food and Drug Administration. U.S. Food and Drug Administration. [May 3, 2016]. (原始内容存档于2016-05-15). 
  51. ^ Patel MR, Hellkamp AS, Fox KA. Point-of-Care Warfarin Monitoring in the ROCKET AF Trial (PDF). The New England Journal of Medicine. February 2016, 374 (8): 785–8 [2022-09-20]. PMID 26839968. doi:10.1056/NEJMc1515842. hdl:20.500.11820/69b742f0-5b6d-4f54-93a5-98a1da909653可免费查阅. (原始内容存档 (PDF)于2018-07-22). 

Read other articles:

История РоссийскаяИсторія Россійская Автор В. Н. Татищев Жанр историография Язык оригинала русский Оригинал издан 1768—1843 Оформление Г. Ф. Миллер, М. П. Погодин Носитель книга «История Российская» (рус. дореф. Исторія Россійская; полное название первого издания: «Исто...

 

Professional ice hockey team based in Virginia Roanoke Rail Yard DawgsCityRoanoke, VirginiaLeagueSPHLFounded2009; 15 years ago (2009)Home arenaBerglund CenterColorsRoyal blue, gold, white     Owner(s)McGinn family[a]Head coachDan BremnerCaptainMac JansenMediaThe Roanoke TimesFranchise history2009–2014Mississippi Surge2016–presentRoanoke Rail Yard DawgsChampionshipsPlayoff championships1 (2022–23) The Roanoke Rail Yard Dawgs are a professional ice...

 

Not to be confused with Steely Dan. English folk rock band, formed 1969 Steeleye SpanSteeleye Span, Glastonbury Festival, 2019Background informationOriginLondon, EnglandGenres British folk rock[1] Years active1969–1978, 1980–presentLabels Park Shanachie Chrysalis Flutterby Mooncrest B&C Spinoffs The Woods Band The Carnival Band Silly Sisters Spinoff ofFairport ConventionMembers Maddy Prior Andrew Sinclair Roger Carey Liam Genockey Julian Littman Athena Octavia Jessie May Smart...

This is a list of candidates in the 2016 Philippine presidential and vice presidential elections. Candidates for President These are people who submitted candidacies, and were allowed to run by the Commission on Elections and to be included in ballots. Jejomar Binay Main article: Jejomar Binay presidential campaign, 2016 Jejomar Binay When he was questioned by the media at the Coconut Palace in September 2011, Vice President Jejomar Binay (UNA) confirmed his plans to run for president.[1&...

 

Pour les articles homonymes, voir Cyclohexadiène. cyclohexa-1,3-diène Identification Nom UICPA cyclohexa-1,3-diène Synonymes 1,2-dihydrobenzène, 1,3-CHD No CAS 592-57-4 No ECHA 100.008.878 No RTECS GU4702350 PubChem 11605 ChEBI 37610 SMILES C1CC=CC=C1 PubChem, vue 3D InChI InChI : vue 3D InChI=1/C6H8/c1-2-4-6-5-3-1/h1-4H,5-6H2 Apparence liquide incolore Propriétés chimiques Formule C6H8  [Isomères] Masse molaire[1] 80,127 7 ± 0,005 4...

 

For other ships with the same name, see USS Raymond. History United States NameRaymond NamesakeReginald Marbury Raymond BuilderConsolidated Steel Corporation, Orange, Texas Laid down3 November 1943 Launched8 January 1944 Commissioned15 April 1944 Decommissioned22 September 1958 Out of service31 May 1960 Stricken1 July 1972 Honors andawards Presidential Unit Citation 5 battle stars for World War II FateSunk as target off Florida on 22 January 1974 General characteristics Class and typeJohn C. ...

Aki KaurismäkiAki Kaurismäki pada 2012LahirAki Olavi Kaurismäki4 April 1957 (umur 67)Orimattila, FinlandiaPekerjaanSutradara film, Produser film dan penulis latarPenghargaanCannes Grand Prix2002 The Man Without a PastCannes Ecumenical Jury Special Mention1996 Drifting CloudsCannes Prize of the Ecumenical Jury2002 The Man Without a PastPenghargaan FIPRESCI2011 Le HavreJussi untuk Film Terbaik2006 Lights in the DuskJussi untuk Film Debut Terbaik1983 Crime and PunishmentJussi untuk Nask...

 

Articles related to waste management include: Contents:  0–9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z See also A Advanced Thermal Treatment Air Pollution Control Alternate Weekly Collections Animal By-Products Order Animal By-Products Regulations Anaerobic digestion Anaerobic Digestion & Biogas Association Approved Code of Practice As Low As Reasonably Practicable Asbestos Containing Material Associate Parliamentary Sustainable Resource Group Association for Organic...

 

DameMaggie SmithCH DBESmith pada tahun 2007LahirMargaret Natalie Smith28 Desember 1934 (umur 89)Ilford, Essex, Inggris[1][2]Tempat tinggalLondon, InggrisKebangsaanInggrisPekerjaanAktrisTahun aktif1952–sekarangSuami/istriSir Robert Stephens ​ ​(m. 1967; c. Kesalahan ekspresi: Operator < tak terduga)​ Beverley Cross ​ ​(m. 1975; meninggal Kesalahan ekspresi: Operator < ta...

Constituency of the Maharashtra legislative assembly in India NiphadConstituency No. 121 for the Maharashtra Legislative AssemblyConstituency detailsCountryIndiaRegionWestern IndiaStateMaharashtraDistrictNashikLS constituencyDindoriReservationNoneMember of Legislative Assembly14th Maharashtra Legislative AssemblyIncumbent Diliprao Shankarrao Bankar PartyNationalist Congress Party (Ajit Pawar Faction)Elected year2019 Niphad Assembly constituency is one of the 288 Vidhan Sabha (legislative asse...

 

Artikel ini perlu diwikifikasi agar memenuhi standar kualitas Wikipedia. Anda dapat memberikan bantuan berupa penambahan pranala dalam, atau dengan merapikan tata letak dari artikel ini. Untuk keterangan lebih lanjut, klik [tampil] di bagian kanan. Mengganti markah HTML dengan markah wiki bila dimungkinkan. Tambahkan pranala wiki. Bila dirasa perlu, buatlah pautan ke artikel wiki lainnya dengan cara menambahkan [[ dan ]] pada kata yang bersangkutan (lihat WP:LINK untuk keterangan lebih lanjut...

 

بطريركية أنطاكية وسائر المشرق للروم الأرثوذكس شعار النبالةالمؤسسالرسولين بطرس و‌بولس.الاستقلالالعصر الرسوليالرئيس الحالييوحنا العاشر يازجي، بطريرك أنطاكية وسائر المشرق للروم الأرثوذكس (17 ديسمبر 2012)المراكزحاليًا: الكنيسة المريمية، دمشق، سورياتاريخيًا: مدينة أنطاكية�...

School of Tibetan Buddhism Statue of the 16th Karmapa at Samye Ling, Scotland, wearing the famed black crown of the Karmapas, the traditional heads of the Karma Kagyu lineage Part of a series onTibetan Buddhism Schools Nyingma Kadam Sakya Bodong Kagyu Jonang Gelug Rimé Key personalities First dissemination Padmasambhāva Śāntarakṣita Kamalaśīla Songtsen Gampo Trisong Detsen Ralpacan Second dissemination Atiśa Talika Abhayakirti Niguma Sukhasiddhi Milarepa Nyingma Yeshe Tsogyal Longche...

 

1955 film Your Life GuardsDirected byHans DeppeWritten byBobby E. LüthgeProduced byJohannes J. FrankWilhelm GernhardtStarringIngrid AndreeGerhard RiedmannWolf Albach-RettyCinematographyWilly WintersteinEdited byJohanna MeiselMusic byWilly MattesProductioncompanyHans Deppe FilmDistributed byDeutsche London FilmRelease date 20 December 1955 (1955-12-20) Running time98 minutesCountryWest GermanyLanguageGerman Your Life Guards or Your Life Regiment (German: Ihr Leibregiment) is a ...

 

American college football season 1904 Nebraska Cornhuskers footballNebraska state championConferenceIndependentRecord7–3Head coachWalter C. Booth (5th season)Home stadiumAntelope FieldSeasons← 19031905 → 1904 Midwestern college football independents records vte Conf Overall Team W   L   T W   L   T Saint Louis   –   10 – 0 – 0 Bethany (KS)   –   7 – 0 – 0 Northern Illinois State  ...

72nd annual meeting of National Football League franchises to select newly eligible players 2007 NFL draftGeneral informationDate(s)April 28–29, 2007TimeNoon EDT (April 28)11:00 am EDT (April 29)LocationRadio City Music Hallin New York City, NYNetwork(s)ESPN, ESPN2, NFL NetworkOverview255 total selections in 7 roundsLeagueNFLFirst selectionJaMarcus Russell, QBOakland RaidersMr. IrrelevantRamzee Robinson, CBDetroit LionsMost selections (11)Atlanta FalconsGreen Bay PackersJacks...

 

اضغط هنا للاطلاع على كيفية قراءة التصنيف الببر التسمانيالعصر: أوائل البليوسين-الهولوسين ببر تسماني في واشنطن العاصمة سنة 1902 حالة الحفظ أنواع منقرضة  (1936) [1] المرتبة التصنيفية نوع[2]  التصنيف العلمي النطاق: حقيقيات النوى المملكة: الحيوانات الشعبة: الحبليات الط�...

 

Group of tribal societies, 5th–10th c. Battle between the Slavs and the Scythians — painting by Viktor Vasnetsov (1881) The early Slavs were speakers of Indo-European dialects[1] who lived during the Migration Period and the Early Middle Ages (approximately from the 5th to the 10th centuries AD) in Central, Eastern and Southeast Europe and established the foundations for the Slavic nations through the Slavic states of the Early and High Middle Ages.[2] The Slavs' original ...

Italian conductor and composer Antonino PalminteriBorn3 October 1846 (1846-10-03)Menfi, ItalyDied31 July 1915 (1915-08-01) (aged 68)Pistoia, ItalyOccupation(s)Composer, conductor Antonino Palminteri (3 October 1846 – 31 July 1915) was an Italian conductor and classical composer. Life and career Born in Menfi, the son of a doctor, in 1970 Palminteri graduated in piano, counterpoint and harmony from the Palermo Conservatory, and a few years later he became Maestrino and Concert...

 

Principati danubianiPrincipatul României Capitale Bucarest Governo Monarchia costituzionale Domnitor Alexandru Ioan Cuza (1851-66) Carlo I (1866-81) Lingua ufficiale Rumeno Esistenza 24 gennaio 1859 — 13 marzo 1881 Valuta Leu Stato successore Regno di Romania Principati di Moldavia e Valacchia nel 1786, mappa italiana di G. Pittori, tratta da cartografia di Giovanni Antonio Rizzi Zannoni. I Principati danubiani in un senso più ampio: Moldavia, Valacchia e Serbia Principati danubiani a me...